头颈癌肿瘤干细胞放射生物学及作用综述
本文综述肿瘤干细胞(CSC)在头颈癌中的表型、放射反应及治疗抵抗机制。CSC约占头颈癌细胞群的1%-10%,在治疗性辐射剂量下比例可能增加,不仅因选择性杀伤,还因其改变分裂动力学并借助微环境支持。CSC被视为治疗失败、转移和复发的驱动因素。
要点
- CSC约占头颈癌细胞群的1%-10%,治疗性辐射剂量下比例可能增加。
- CSC比例增加不仅因选择性杀伤,还因其改变分裂动力学并借助微环境支持。
- CSC被视为治疗失败、转移和肿瘤复发的驱动因素。
核心结论
- CSC具有与正常干细胞相似的属性,驱动头颈癌进展和治疗抵抗,其比例在治疗性辐射剂量下可能增加。
- CSC可能被视为治疗失败、转移和肿瘤复发的驱动因素,也是头颈癌死亡的主要原因。
研究设计与样本
- 综述,总结肿瘤干细胞在头颈癌中的表型、放射反应及治疗抵抗机制。
主要发现
- CSC通常约占头颈癌细胞群的1%-10%,在治疗性辐射剂量下比例可能增加。
- CSC比例增加不仅因选择性杀伤,还因其改变分裂动力学并借助微环境支持治疗抵抗和增殖。
- CSC代表癌细胞异质性层级顶端,可能被视为治疗失败、转移和肿瘤复发的驱动因素。
- 超过90%的头颈癌为鳞状细胞癌(HNSCC),其中人乳头瘤病毒(HPV)参与的报告发病率增加。
关键数值与推荐
- CSC通常约占头颈癌细胞群的1%-10%,在治疗性辐射剂量下比例可能增加。
- 超过90%的头颈癌为鳞状细胞癌(HNSCC)。
临床怎么用
- 放化疗联合手术切除是控制与治愈HNSCC的首选干预。
- 鉴于CSC的治疗抵抗和辐射后增殖反应,识别和理解该亚群的放射生物学对其靶向清除至关重要。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evidence of cancer cells that bear attributes analogous to those of normal stem cells has developed a hierarchical model of cancer's architecture and progression. This subset of cancer stem cells (CSCs) drives the progression and therapy resistance of cancers. Research to identify the phenotypes of these CSCs presents evidence of a subpopulation that is more resistant to therapy and may proliferate in response. Literature shows that CSCs typically represent around 1%-10% of cell populations in head and neck cancer but this proportion may increase in response to a therapeutic radiation dose. This is shown to be not just as a result of preferential killing, but also their capacity to alter divisional dynamics and enlist the support of a complicit microenvironment in therapy resistance and proliferation. The CSCs represent the apex of a hierarchy in the heterogeneity of cancer cells and may be seen as the agents of treatment failure, metastasis, and tumor recurrence, the principal cause of mortality in head and neck cancers. Greater than 90% of head and neck cancers are squamous cell carcinomas (HNSCCs), and among these an increasing incidence of the involvement of the human papillomavirus (HPV) is reported. Chemoradiotherapy along with surgical resection are the interventions of choice for control and cure of HNSCC, but given CSCs therapy resistance and proliferative responses to radiation, the identification and understanding of the radiobiology of this subpopulation is critical to their targeted elimination. This article reviews the current evidence on CSC generally and in HNSCC specifically to identify their phenotype, evaluate their responses to radiotherapy, and evaluate the defensive mechanisms used to resist therapeutic control.
引用
- Reid PA, Wilson P, Li Y, et al. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers. Head Neck. 2017. PMID: 28644558. doi:10.1002/hed.24848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。